Murray discusses the upcoming Violence Against Women Act Reauthorization and Listens to Current Challenges;
Announces she will re-introduce the SAFE Act
“While I was pleased to receive assurances that the agency will, in the coming weeks, deliver a long overdue decision on Plan B, concerns about
(WASHINGTON, D.C.) – U.S. Senator Patty Murray (D-Wash.) today voted against the nomination of Lester Crawford as FDA Commissioner. Murray, who released her ‘hold’ on
Decision On Over-The-Counter Sales Of Emergency Contraceptives Will Be Made By September 1
Senator applauds Seattle Storm, speaks of own experiences with athletics
